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OPTIC NERVE ATROPHY: A COMPARISON OF TWO IMAGING 
MODALITIES TO EVALUATE THEIR SENSITIVITY FOR DIAGNOSTIC 
PURPOSES 
 
ANH-DAO M. CHENG 
 
ABSTRACT 
Purpose: To evaluate the efficacy of MRI as a diagnostic tool by comparing it to 
OCT in patients with suspected optic nerve atrophy. Currently, MRI is an 
established noninvasive imaging modality for tumors and inflammatory tissues; 
however their use in optic nerve atrophy is limited to advanced cases. Our study 
investigates the use of OCT, a more sensitive imaging modality, compared to 
MRI as a potential adjunct to the clinical diagnosis of optic nerve atrophy. 
 
Methods: This retrospective study analyzed 27 medical records (40 eyes) of 
patients with suspected optic nerve atrophy referred to the Neuro-ophthalmology 
Clinic of the Beth Israel Deaconess Medical Center (2009-2016) who had both 
MR imaging of the orbits and SD-OCT scans. Based on the RNFL thickness 
obtained from OCT scans, optic atrophy was defined as border, mild, moderate, 
or severe. MRIs were used to measure the optic nerve area, optic nerve diameter 
and sheath area of all eyes. From there, the ratio of optic nerve area to sheath 
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area, percent difference in optic nerve diameters in a patient and percent 
difference in optic nerve areas in a patient were determined.  
 
Results: As atrophy worsens, the optic nerve area and sheath area seem to 
steadily decline. The ratio between the two seems to remain constant (0.27) 
regardless of degree of atrophy. Focusing on unilateral patients, the percent 
difference in optic nerve area with mild optic atrophy seemed minimal (14%). It 
becomes more significant in moderate and severe atrophy cases (56.06% and 
26.18% respectively). Overall, there does not seem to be a strong correlation 
between MRI measurements and OCT RNFL values.  
 
Conclusions: Overall, a strong correlation was not found between MRI 
measurements and OCT RNFL thickness values. While a general trend existed, 
there was too much variation to determine cut off points for atrophy based solely 
on the measurement of a single eye. MRI may be useful in identifying severe and 
moderate optic nerve atrophy especially in unilateral patients. Once the RNFL 
thins to about 70 μm, the difference in size is detectable on MRI. For all cases of 
mild optic atrophy and bilateral moderate atrophy, OCT remains a more reliable 
imaging diagnostic. Changes in nerve size appear minimal compared to a 
healthy human. The optic nerve sheath was also shown to decrease in size in 
cases of atrophy. Future studies with a larger sample size are needed to produce 
more conclusive results. 
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INTRODUCTION 
 
The sense of sight is invaluable for maintaining our quality of life. Humans 
rely heavily on it for perception of and engagement with the surrounding 
environment. Therefore, preserving and protecting vision is crucial. Optic nerves 
relay visual information to the visual cortex. The optic nerve is susceptible to 
damage from a large number of disorders, including disease processes which 
afflict other organ systems as well. The end result of this damage is optic nerve 
atrophy. This purpose of this study was to explore the diagnosis of optic nerve 
atrophy through two different diagnostic imaging methods, magnetic resonance 
imaging (MRI) and optical coherence tomography (OCT). OCT, the more 
sensitive imaging technique, is a currently established imaging method for 
diagnosis of optic nerve atrophy along with clinical evaluation. However, this 
study questions if MRI would also serve as a useful diagnostic tool in conjunction 
with clinical evaluation. 
 
Anatomy of the Eye 
The eyeball functions as a complex sensory organ, receiving visual input 
from its surroundings. It is composed of multiple structures (Figure 1) and may be 
organized into the anterior and posterior segment. The anterior segment refers to 
the part of the eye in front of the vitreous humor. Major components include the 
ciliary body, cornea, iris and lens. The cornea is the outermost protective layer of 
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the eye and also serves to focus light rays onto the retina. The iris contains 
circular and radial muscle fibers, capable of controlling the diameter of the pupil 
in response to the intensity of light in the environment. The ciliary body provides 
nourishment to the anterior segment by producing aqueous humor. Behind the 
aqueous humor is the lens, which also focuses light rays onto the retina. The 
back portion of the eye is known as the posterior segment. The vitreous fills the 
space between the lens and the retina. (1) 
Figure 1- Anatomy of the eye. The major components of the eye are labeled in the 
diagram. Features to the right and including the lens may be considered the anterior 
segment of the eye. Structures behind the lens are considered part of the posterior 
segment. Figure taken from Barrett K et al., 2010(1).  
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The retina is a multilayered structure found behind the vitreous cavity. 
(Figure 1). The retina converts light rays to electrical signals for the brain to 
process. Six types of neurons reside within the retina and form the layers. (Figure 
2) The photoreceptors are located closest to the choroid, the blood vessel 
system that nourishes the retinal pigment epithelial layer. Because of the location 
Figure 2 - Layers of the Retina. The multiple layers of the retina and the cells that 
make up each layer are illustrated. The top layer in the image is the innermost layer 
of the retina. Light rays must pass through all the other layers of the retina starting 
with the inner limiting membrane to reach the rods and cones where they may be 
converted into electrical signals. Figure taken from Gray H, 1918 (2).  
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of the photoreceptors in the 
outermost layer, light rays must 
penetrate through the majority of 
the eye structure and all the other 
interneurons to reach them. The 
purpose of the photoreceptors is 
to convert the light rays to 
electrochemical signals for the 
cerebrum to process. The two 
types of photoreceptors are rods 
and cones. Rods allow for low 
light vision but at the expense of visual acuity. Cones allow color vision and 
higher visual acuity. Cones are further categorized into S-, M- and L- cones 
based off of the particular peak wavelength that excites the individual 
photoreceptor. The largest collection of cones is located in the fovea. 
Consequently, this area corresponds to the highest visual acuity. In funduscopic 
photographs, the fovea appears as an indented region within the macula. The 
fovea is a yellow region of the macula that also contains a high concentration of 
cones. It plays an integral role in central vision. (Figure 3) (1) 
Other retinal interneurons are the amacrine cells, bipolar cells, ganglion 
cells, and horizontal cells. The innermost concentric layer of the retina consists of 
retinal ganglion cells. Neurotransmission moves radially inwards from the rods 
Figure 3- Fundus Photo of the Right Eye. The 
optic disc, macula and fovea are visible and 
appear normal. Figure taken from Biousse 2016 
(3) 
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and cones to the retinal ganglions. (Figure 2) The unmyelinated axons of these 
cells lead toward the optic disc and out of the eye. This layer of axons is termed 
the retinal nerve fiber layer (RNFL). This is the starting point of the optic nerve, 
which is myelinated. Because the optic disc is where the axons leave the eye, 
there is a deficit of photoreceptors there, causing it to be a blind spot. (1) 
 
Optic Nerve and Visual Pathway 
The optic nerve is one of the 
twelve cranial nerves. It is made of 
approximately 1.2 million ganglion 
axons. Feeding out of the posterior 
end of each eye and passing through 
the optic chiasm, the nerve terminates 
in either the right or left lateral 
geniculate body (LGN) of the 
thalamus. Depending on the origin of 
the ganglionic axon, the axon may 
transverse to the opposite side of the 
brain at the chiasm. (Figure 4) Once in 
the thalamus, the ganglionic axons 
synapse onto one of six layers of the 
Figure 4 - Visual Pathway. Light rays are 
converted into an electrical pulse at the 
retina in the eyes and then they travel 
through the optic chiasm, optic tracts to the 
LGN. From there, they proceed to the visual 
cortex of the brain. Adapted from Barrett K 
et al., 2010(1).    
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LGN.  Layers 1 and 2 consist of the magnocellular cells that convey information 
about movement and depth perception. Layers 3 to 6 consist of the parvocellular 
cells that convey information about color, shape and texture. Interspersed 
between the layers are the koniocellular cells (interlaminar cells). Koniocellular 
cells carry information about color. All six layers have optic radiations that lead to 
the visual cortex of the brain, specifically Brodmann’s area 17. That region is also 
divided into six layers. The magnocellular and parvocellular pathways terminate 
in layer 4. However, the koniocellular cells terminate in layers 2 and 3 (1). After 
separating the koniocellular pathway, magnocellular and parvocellular signals 
from both eyes can be combined and processed in parallel.  The cortex uses 
orientation columns and ocular dominance columns for image processing.  
Some retinal ganglion axons do not synapse in the thalamus. Instead, 
they terminate in the pretectal portion of the midbrain. These neurons are 
involved with the pupillary light reflex. The pupillary light reflex is a response to 
light being shone into an eye. Both the pupil of the eye closest to the light and the 
pupil of the other eye will constrict in response to the brightness. The reflex 
pathway flows from the retina to the pretectal nucleus. From there, the third order 
neurons synapse in the Edinger-Westphal nucleus. Those parasympathetic 
neurons then connect to the ciliary ganglion neurons, which control the sphincter 
muscle of the iris. (1) Because of this reflex pathway, the intensity of light 
reaching the retina can be regulated by constricting the pupil in response to 
brightness.   
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Optic Nerve Atrophy 
 Optic nerve atrophy results from 
damage to the nerve fibers in the optic 
nerve. Damaged nerve fibers are 
unable to transmit electrical signals 
from the retina to the occipital cortex. 
Consequently, vision may become lost 
to varying degrees. Atrophy is a 
potential long term complication of 
multiple optic neuropathies. The optic 
nerve is comprised of the nerve sheath 
and retinal ganglion axons. Loss of retinal ganglion axons causes a reduction in 
the size of the optic nerve. Demyelination may also contribute to the thinning of 
the optic nerve. (5)  Depending on the site of the underlying pathology, the 
damage to the nerve could cause either anterograde degradation (Wallerian 
degeneration) or retrograde degeneration. (6) Different etiologies will result in 
separate sites of damage. Ischemic optic neuropathy and glaucoma tend to 
damage the anterior optic nerve while optic neuritis tends to damage the 
retrobulbar portion. Location of the damage determines the type of visual field 
defect found on examination of the patient. For example, damage to the 
intraorbital portion of the nerve may cause a central scotoma. However, damage 
to the optic chiasm could cause a bi-temporal hemianopia. (7) The site of injury 
Figure 5- Atrophic Optic Nerve. The optic 
disc appears pale and diffuse, indicating 
nerve atrophy. In this particular patent, 
atrophy was caused by a pituitary adenoma 
pressing on the optic chiasm. Taken from 
Biousse 2016 (3) 
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does not affect the overall amount of loss in the RNFL but the extent of the injury 
does. (5) 
 Diagnosis of optic nerve atrophy is normally made through both clinical 
and ophthalmological examination. Clinical symptoms vary between the optic 
neuropathies. (Table 1) Onset may be rapid or gradual. Common symptoms and 
findings are vision loss with or without eye pain, visual field defects such as 
central scotoma, color vision difficulties, decreased contrast, decreased visual 
acuity, and abnormal pupillary light reflex. Demyelinating optic neuropathy may 
be associated with the Uhtoff’s phenomenon, which is the worsening of 
neurological symptoms due to increased body temperature. (8) During fundus 
examination, the ophthalmologist may notice changes to the optic nerve. The 
nerve may appear diffusely pale or may exhibit partial pallor. (Figure 5) With 
severe atrophy, all optic discs will display diffuse pallor. (3) This indicates optic 
nerve atrophy.   
Optic atrophy may affect individuals at any age. The most probable 
underlying etiology varies based on age at presentation. In children, the most 
common cause of optic atrophy appears to be complications from premature  
 9 
 
Table 1- Common Optic Neuropathies and Their Clinical Features. The clinical 
symptoms of each pathology may vary. All of these have the potential to result in optic 
nerve atrophy. Table taken from Behbehani, 2007 (8) 
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birth. Complications include intraventricular hemorrhage, hydrocephalus, and 
retinopathy of prematurity. (9) Retinopathy of prematurity is abnormal growth and 
branching of blood vessels in the retina in premature infants, especially those 
that receive neonatal care with oxygen. This disease is sometimes associated 
with fibrous tissue growth. Such growth increases the risk of retinal detachment. 
(10) Following complication from premature birth, tumors are the second most 
common cause in children. The tumors that could cause atrophy are pilocytic 
astrocytoma and craniopharyngioma. (9)  
In children, the underlying etiology has shifted throughout the decades. 
Retrospective studies looking at causes of childhood optic nerve atrophy were 
completed in the late 1960s and late 1980s. In the 1980s study, Repka and Miller 
found tumors to be the most common etiology in children with prematurity 
complications and hydrocephalus being less common. (11) In the 1960s study, 
Costenbader and O’Rouck found hereditary causes to be the most common. 
(12). It should be noted that Costenbader and O’Rouck were only able to identify 
50% of the etiologies in their subject (12) and Repka and Miller were able to 
diagnose 89%. (11) The most recent study by Mudgil identified the etiologies in 
96% of their subjects. (9) Regardless, there still seems to be a general shift in 
causes of atrophy, which has been attributed to more premature infants living 
and improvements in neuroimaging studies. (9) 
In patients over the age of 50, ischemic optic neuropathy is the most 
common acute optic neuropathy. (3) Ischemic optic neuropathy (ION) results 
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from restricted blood flow at any portion of the optic nerve from the optic nerve 
head to the optic chiasm. The disease is categorized as either anterior or 
posterior based on the location of damage. It can be furthered classified as 
arteritic or non-arteritic ION. Arteritic ischemic optic neuropathy is associated with 
giant cell arteritis also known as temporal arteritis. Giant cell arteritis is 
characterized by inflammation of medium sized blood vessels, especially those 
located in the temples. Non-artheritic anterior ischemic optic neuropathy is the 
most common with a prevalence of 2.3 to 10.3 per 100000 population per year. 
(13) The underlying etiology of non-arteritic anterior ION is hypoperfusion of the 
optic nerve head due to thrombosis, systemic hypotension, or atherosclerotic 
disease. (14) In patients with multiple sclerosis (MS), there is a potential to 
develop optic neuritis, which is the presenting symptom in about 20% of patients 
with MS. (15) The entity is more common in females between the ages of 30 and 
40 years old. (16) Decreasing RNFL thickness in MS is correlated to reduced low 
visual contrast acuity. (17) As seen in Table 1, there are many other potential 
causes of atrophy.  
Currently, reversing the damage from optic nerve atrophy is not possible. 
Once the retinal ganglion axons are lost, the neurons are unable to regenerate 
them. Therefore, any changes in vision as a result of atrophy is permanent. 
Treatment options are focused on addressing the underlying etiology instead. 
Because of the various different etiologies, treatment also varies from steroids in 
cases like optic neuritis to surgical excision or radiation therapy in cases of 
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compressive optic neuropathies caused by pituitary adenomas. (3,8) Since 
retinal ganglion loss is irreversible, early detection and intervention are vital. 
Minimizing the amount of damage done is imperative to preserving vision. 
 
Magnetic Resonance Imaging 
Currently, there are multiple available imaging techniques available for 
viewing the orbits and optic nerve. This include computerized tomography, 
confocal scanning laser ophthalmoscopy, MRI, OCT and scanning laser 
polarimetry. Introduced in the 1980s, MRIs have become a popular noninvasive 
imaging modality, even replacing computerized tomography in many instances 
except for cases where MRIs are unavailable or contraindicated. MRIs are 
particularly useful in neuro-ophthalmology since they permit the imaging of the 
cranial and orbital nerves. They allow for inspection of the head for any mass 
lesions or inflammatory process that could be affecting the visual pathway.  
However in cases of optic nerve atrophy, a clear diagnosis can only be made 
with an MRI in advanced clinical cases. (18)  
MRI technology is based on the physics principles of nuclear magnetic 
resonance. By placing the subject within a strong electromagnet, the atoms of 
the body, particularly hydrogen atoms, will re-arrange their proton spins to align 
with the external magnetic field, which may be 1.5 T to 3 T. (19) Radio wave 
pulses, produced from the machine, excite the aligned protons. Excitation will 
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cause the protons to fall out of alignment. As the pulse dissipates, the protons 
emit a radio wave as they return to their original configuration within the magnetic 
field. The emitted radio wave is detected by the MRI machine and used as data 
points for the image. The degree of excitation and time to return to the original 
stable state is dependent upon the tissue that the atom resides in. These 
differences result in formation of an image. In addition to the large electromagnet, 
smaller gradient magnets may be used to induce secondary magnetic fields to 
influence the directionality of the 
protons. Two important parameters to 
consider with MRI are T1 and T2. T1 
and T2 refers to the spin-lattice 
relaxation time and the spin-spin 
relaxation time respectively. (20) For 
imaging of the optic nerve, MRIs of the 
orbits use fast spin-echo (FSE) 
coronal T2-weighted and fast inversion 
recovery T2-weighted imaging 
protocols.  
 Each anatomical feature has a 
specific MRI protocol to maximize 
details and minimize artifacts. 
Compared to the rest of the central 
Figure 6 - MRI of the orbits, axial plane 
FSE T2 weighted images. Top Image 
shows MRI of healthy optic nerve. Bottom 
image. Bilateral Optic Atrophy. Taken from 
Mashima et al 1996 (22) 
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nervous system, imaging of the visual pathway is slightly more tedious. A high 
resolution is required for imaging of the small area occupied by the eyes. 
However, the image must also encompass the entire brain while maintaining a 
reasonable scanning time for the subject. In T1-weighted scans, there is a great 
deal of visible anatomical detail because of a high signal to noise ratio. Fat has a 
short T1 constant. Consequently, T1-weighted MRIs of the orbits tend to have 
strong brightness around the eyes due to the amount of orbital fat. This can 
result in artifacts. (21) In T2-weighted MRI sequences, fluids appear bright while 
fat and bone appear darker. (20) (Figure 7) Therefore, using this scanning 
technique for MRI of the orbits permits visualization of inside the eyeball. This 
scanning sequence is more 
susceptible to motion artifact though. 
(21) In the case of the visual 
pathway, MRIs are not sensitive to 
axon integrity. (22) (Figure 8) 
 In addition to the weighted 
MRI sequence, contrast and fat 
suppression are necessary for 
imaging of the eyeballs and visual 
pathway. To increase contrast, a 
gadolinium based contrast agent is 
injected into a vein of the subject. 
Figure 7 - MRI of the orbits, coronal plane 
FSE T2 weighted images. Top Image shows 
MRI of healthy optic nerves. Bottom image 
shows bilateral optic atrophy. Taken from 
Mashima et al 1996 (22) 
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This increases the detail in the vascularized portions of the cranial scan by 
altering the T1 constant of the surrounding tissues. The agent is later eliminated 
through the kidneys. (21) Since renal function should be normal for elimination, 
patients do undergo pre-screening prior to their MRI. Fat suppression techniques 
like short tau inversion recovery minimizes the brightness of intraorbital fat on the 
MRI scan. Imaging of the optic nerve and optic chiasm seems to be best 
completed using fat suppression T2 weighted MRI sequences or fat suppression 
T1 weighted MRI sequences before and after contrast. (19)  Furthermore, use of 
a FSE T2-weighted sequence allows for more rapid image acquisition. This 
produces a more comfortable imaging process for the patient and minimizes the 
chance of developing motion artifacts. Additionally, use of FSE sequence can 
resolve up to 0.73 mm by 0.54 mm with a 3 mm depth resolution. During MRI of 
atrophic nerves, there are high intensity signals around the base and in the optic 
canal. The subarachnoid space is also enlarged compared to normal nerves, 
suggesting greater decrease in nerve than sheath. (23)  
MRI is an established imaging modality for the visual pathway. It has been 
used for the diagnosis of ocular and orbital tumors. It has also been used for the 
detection and assessment of damage in glaucoma, diagnosis of congenital tilted 
disc syndrome, and even diagnosis of retinal detachments. However due to 
resolution, artifact potential, and cost, MRI of the orbits is not the most optimal 
imaging method. In cases of optic atrophy, it only detects the complication once 
atrophy has progressed into a serious condition. (18) 
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Ocular Coherence Tomography 
Introduced in the early 1990s, OCT is a non-invasive scan used for 
imaging of the retina. It is used as an early diagnostic tool for potential retinal and 
optic disc disorders such as epiretinal membrane, glaucoma and macular edema. 
(24) OCT uses low coherence interferometry to create scans of the posterior 
portion of the eye by applying the same physics principles used in 
ultrasonography. Accordingly, much of the terminology remains interchangeable 
when describing the two modalities. The OCT instrument emits light waves and 
images are generated based on the properties of the returning waves. 
Absorption, back-scatter and time-delay are the major attributes that determine 
image contrast. Absorption and back-scatter of the light rays are influenced by 
the optical characteristics of the anatomical microstructures. For instance, 
structures like the RNFL and choriocapillaries have a high reflective quality, 
rendering them bright on the OCT scan. (Figure 8) Time delay of the echoes are 
influenced by the depth of the structure. Each returning wave produces a data 
point known as an A-scan. Multiple A-scans are taken and compiled together to 
produce a B-scan, which is a cross-sectional image of the retina. Multiple B-
scans can be compiled to create a C-scan. This allows for three-dimensional 
visualization of the retina.  
 17 
Although based on the same principles, ultrasonography and OCT differ 
greatly with OCT being a more efficacious imaging modality for the eyes. 
Ultrasonography utilizes ultrasound wave pulses while OCT utilizes a continuous 
near-infrared light wave. There are a number of advantages to using a light 
wave. Firstly, the eyeball does not need to be in contact with a saline solution in 
order for the wave to be transmitted from the probe to the eye. Secondly, the use 
of a near-infrared light wave is significant because the photoreceptors are not 
highly sensitive to that end of the light spectrum. Therefore, the pupillary light 
Figure 8 - OCT scans of the Retina. Top image shows a healthy retina and the areas 
area labelled. Note how the RNFL and choriocapillaries are colored bright red. This 
indicates a high reflective nature of the structures. Bottom image shows the retina has 
been damaged by non-artertitic anterior ION There is serous detachment near the optic 
disk. Top figure taken from Hee 1995 (24) Bottom figure taken from Hayreh 2009 (25). 
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reflex is not stimulated and the pupil does not constrict. The pupil remains wide 
for light rays to pass through and back out during the scan. Thirdly, OCTs are 
capable of generating a greater resolution at around 10 μm (24) with a B-scan 
image capture time of about 2.5 seconds. By comparison, ultrasounds can only 
resolve up to 150 μm and MRIs of the orbits require a scanning time of about 20-
35 minutes. In summary, OCTs are able to generate highly detailed images while 
minimizing subject discomfort during the shorter imaging process.  
There are additional benefits to using OCT. The imaging process is not 
strongly compromised by the presence of cataracts. Even though image quality is 
reduced, the OCT scan and RNFL values remains a reliable diagnostic tool along 
with clinical examination for retinal problems. (26) While MRIs take into account 
the myelin surrounding the optic nerve, OCTs measure only the retinal ganglion 
nerve axons. This may mean that OCTs are capable of providing a more 
accurate measurement for the size of the optic nerve. Thinning of the RNFL is 
directly correlated with decreasing visual ability. (27) OCT may be able to detect 
RNFL changes before clinical symptoms present so that the underlying pathology 
may be addressed before any potential vision loss or problems. (28) 
Although relatively new, OCTs have evolved in the way that the programs 
analyze data. Initially, analysis was based on a time-domain method. However, 
there has been a shift to spectral domain analysis. (22) Time-domain OCT (TD-
OCT) is the classic form of OCT. To complete its analysis, the instrument relies 
on the differences in time delay of returning waves to calculate depth. These 
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times are compared to a control echo determined using a moving mirror on the 
reference arm. Based on those values, macular and retinal thickness can be 
determined. (29) In the last decade, spectral-domain OCT (SD-OCT) has slowly 
replaced time-domain analysis. SD-OCT (also known as Fourier domain OCT) 
analyzes the returning optical waves by applying a Fourier transform to the wave 
frequencies to generate its images. This allows for elimination of the reference 
arm mirror. (22)  
In comparison to the TD-OCT, the SD-OCT results in less artifacts, 
greater acquisition speed, and greater resolution. Resolution has changed from 
10 μm in TD-OCT to 5 μm in SD-OCT because of an increase in A-scans. (22) 
The early TD-OCT models were able to take 400 A scans while current SD-OCT 
instruments are capable of acquiring tens of thousands of A-scans depending on 
the brand. In subjects without high myopia, the SD-OCT consistently found 
higher RNFL values than the TD-OCT. (30) As the thickness of the RNFL 
increased, the discrepancy between the TD-OCT and SD-OCT increased. This 
discrepancy could be caused by the fact that the TD-OCT and SD-OCT are using 
different boundaries. (30) TD-OCT normally define their boundaries as the 
internal limiting membrane and the junction between the internal nuclear and 
external plexiform layers. (31) SD-OCTs on the other hand could be calculating a 
further external boundary, like the retinal pigment epithelium. However, programs 
for calculating the external boundary vary from machine to machine so the actual 
boundary could vary. From SD-OCT, average RNFL thickness for a young non-
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diseased eye was 99.4 ± 9.7 μm based off a Cirrus HD-OCT machine. (32). Our 
study examined OCT scans from a Heidelberg SD-OCT instrument. 
 
Significance  
 Optic nerve atrophy is a late complication of optic neuropathies that can 
result in permanent vision loss. Early detection and treatment is key to preserving 
eyesight. As previously mentioned, OCT scans are an established imaging 
modality for detection of optic atrophy. With a spatial resolution of 5 to 10 μm (22, 
24), OCTs are undoubtedly a sensitive clinical imaging method. On the other 
hand with a best resolution of 250 μm (33), MRIs of the orbits are limited in their 
diagnostic ability for atrophy until the damage has become severe. (20) We are 
unaware of any other studies that have directly compared the diagnosis of optic 
nerve atrophy from MRI and OCT. The purpose of this paper is to establish the 
diagnostic efficacy of MRI and OCT by comparing values obtained from each.  
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METHODS  
 In this retrospective study, the medical records of patients with suspected 
optic nerve atrophy were accessed for the purpose of obtaining MRI and OCT 
measurements. These values were gathered and analyzed to determine the 
potential viability of using MRI as a diagnostic aid along with clinical evaluation for 
optic nerve atrophy. 
 
Subjects: 
 This investigation included patients with suspected optic nerve atrophy 
seen at the Neuro-Ophthalmology Service of the Beth Israel Deaconess Medical 
Center by one clinician between June 2009 and December 2016. The Neuro-
ophthalmology database was used to identify the patients. All of the patients 
studied had previously undergone both MR Imaging of the orbits and OCT imaging. 
A start date of June 2009 was chosen to maintain uniformity amongst all the OCT 
scans because this date marks the acquisition of an SD-OCT instrument in the eye 
clinic. Prior to that date, a TD-OCT instrument was in use. Patients with ocular 
comorbidities that could confound OCT were excluded from this investigation. 
Approximately 300 cases were screened. From those records, 27 patients with 
suspected nerve atrophy were included for analysis. An additional thirty patients who 
had received prior MR imaging per the seizure protocol and had no listed ocular 
diagnoses were included to serve as controls for the MRI measurements.   
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MR Imaging: 
Standard coronal MR images of the orbits obtained for clinical MRI studies 
of the patients were included in this study. Each subject was assigned a case 
number. Images were analyzed on GE PACS workstation using available 
measurement tools. Following standard orbital MRI protocol, the MR images had 
been obtained using either a Fast Spin-Echo T2 weighted with fat suppression or 
Fast Inversion Recovery T2 weighted imaging procedure. A radiology resident from 
Beth Israel Deaconess Medical Center Department of Radiology interpreted the 
images and determined the cross-sectional area of each optic nerve, optic nerve 
sheath area, and the optic nerve diameter. For this assessment, diameters were 
defined from superior to inferior quadrant in case of any obliqueness in the nerves. 
By outlining the specified area with a mouse driven cursor, the resident determined 
the area of the encapsulated region through a computer program that returned the 
value. Ideally, all MRI measurements were to be taken 
at the retrobulbar location to minimize obliquity. This 
region contains the largest intraorbital component and 
surrounding CSF space. (23, 34) This would have 
reduced any possible error in measurements. However 
due to varied image quality amongst the cases, 
measurements were instead taken at one of the 
following locations: orbital apex, anterior to orbital apex 
Figure 9- Optic Nerve 
and Sheath. This image 
shows the approximate 
shape of the nerve on 
coronal MRIs 
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or midorbit if the retrobulbar slice was unavailable or of subpar quality for 
measuring the nerve.   
From those measurements, ratios of the optic nerve area to sheath area 
were calculated. Optic nerves in each patient were compared to the opposite optic 
nerve to determine if they were symmetric or if one was smaller than the other. 
Percentage differences between two sets of eyes were calculated for optic nerve 
diameter and optic nerve area. The same measurements were gathered from the 
MRI control group for optic nerve size.  
 
OCT: 
 OCT imaging of the case patients had been obtained on a Heidelberg 
Engineering Spectralis SD-OCT. The machine calculated the RNFL thickness of 
each quadrant of the eye and also an average RNFL for the eye. Based on the 
average RNFL thickness, the degree of atrophy was determined for each eye. An 
average RNFL falling within the range of 70 to 85 μm correlates to the lowest 5th 
percentile and was considered to be ‘mild’ atrophy. An average RNFL within the 
range of 50 to 70 μm corresponds to the lowest 1st percentile and was considered 
‘moderate’ atrophy. An average RNFL of less than 50 μm was considered ‘severe’ 
atrophy. Since the MRI control group had no listed ocular diagnoses, none of them 
received OCT scans and thus no RNFL data is available for them.  
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RESULTS 
 
 
 Out of the 300 screened medical records, a total of 27 patients with optic 
nerve atrophy were included in the study. At the time of imaging, patient ages 
ranged from 32 to 89 years old with the median age being 59 years old. Fifteen of 
the patients were female and twelve were male. Of the total 27 cases, fourteen of 
the cases were afflicted with unilateral optic nerve atrophy while the remaining 
thirteen cases had bilateral optic atrophy. Therefore, a total of forty eyes with 
atrophic nerves were analyzed in the study. Causes of atrophy in patients varied 
from inflammatory, infectious and neoplastic processes to toxic or nutritional 
etiology. In some cases, the underlying etiology was unable to be determined.  
 Comparing the RNFL and optic nerve size of all eyes in pathologic patients, 
a polynomial best fit line demonstrated a positive coefficient of determination of r2 
= 0.49 (Figure 10). As the RNFL decreases as the atrophy worsens, the optic nerve 
area visible in the MRI will also decrease.  
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 While accessing the MRIs, it became apparent that the quality of the images 
varied between patients and in some cases caused limitations. In three patients 
(two unilateral and one bilateral atrophy), their orbital MRIs exhibited hyperintense 
STIR signals which may have resulted in erroneous measurements. Removing 
these four data points from the data set reduces the coefficient of determination 
for RNFL to optic nerve area to r2 = 0.34 (Figure 11) but allows for use of a linear 
equation to describe the fit. A polynomial best fit line still provides the best 
representation but with only a slightly better coefficient of r2 = 0.38. 
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Figure 10 - Comparison of RNFL to Optic Nerve Size. While there are some clear 
outliers and variance, the trend seems to support a correlation between thinning of the 
RNFL and a reduction in optic nerve size. 
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Figure 11 - Comparison of RNFL to Optic Nerve Size without Hyperintense Data 
Points. Removal of hyperintene patient data points allowed the use of a linear best fit line 
and showed a stronger correlation between the two parameters. 
 Nerve sheaths were consistently circular in all MRIs. On the other hand, the 
optic nerves themselves sometimes appeared slightly oblique even at the 
retrobulbar location. Measurements were made at multiple locations and the 
degree of obliqueness most likely varied due to that. Consequently, measurements 
were taken for both diameter and cross-sectional area of the optic nerve.   
 Anecdotally, the interpreting radiology resident noted that a change in optic 
nerve size appeared to correspond with a change in optic sheath size. Calculating 
the ratio between cross-sectional areas of the optic nerve to the areas of the optic 
sheath found the average to be 0.27 ± 0.08. There appears to be minimal 
correlation, r = 0.26, between the ratio and a decrease in RNFL (Figure 12).  
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Figure 12 - Comparisons of RNFL to Area Ratios. There is a weak positive correlation 
between the two parameters and removal of the patients with hyperintensity weakens the 
correlation. Previous literature has found that in optic nerve atrophy, the sheath tends to 
also shrink.  
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 By focusing on the eleven patients with unilateral optic atrophy, the atrophic 
state of the nerve may be compared to a standard “healthy” eye for that patient. 
Thus the other eye served as a control for the patient. By focusing on percent 
differences between the set of eyes, a strong coefficient of determination, r2 = 0.63, 
was found between the percent differences and the RNFL thickness of the atrophic 
eye.  
 
 
Figure 13 - Comparison in Unilateral Patients. In unilateral patients, the eye with 
atrophic RNFL may be considered the control size for the patient. As the RNFL thins, the 
percentage difference in size increases exponentially. The given inverse exponential 
equation provides a strong fit for the data.  
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 Thirty patients were included in the MRI control group, meaning sixty eyes 
were available for analysis. Between sets of eyes, there was an average 
asymmetry of 0.3 mm2. Comparison of the age of the group to their optic nerve 
area found a correlation of r = 0.3063. Calculating the correlation between age in 
the pathological patients and their optic nerve area returned a value of r = 
0.1646. Using a Fisher z-transformation, a two-tail z-test for the two groups 
returns a p-value of 0.4902. Evaluating at a significance level of 0.05, the two 
correlations were determined to be not significantly different.  
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DISCUSSION 
 
 Due to its ability to measure the thickness of the RNFL, OCT is an 
established imaging modality for assisting in the diagnosis of optic nerve atrophy 
along with clinical examination. On the other hand, MRI, a more common 
imaging modality for various other diagnoses and disease monitoring, is primarily 
limited to diagnosing severe cases of optic nerve atrophy. (18) The objective of 
this retrospective study was to determine if orbital MRIs may aid in the diagnosis 
of non-severe cases of optic atrophy.   
 Focusing on both diseased and non-diseased eyes in patients with optic 
atrophy, a weak, positive correlation of r = 0.26 existed between the RNFL 
thickness and the cross-sectional area of the optic nerve. Since concern about 
erroneous hyperintense signals existed, the correlation was re-calculated 
excluding those four data points. The resulting correlation was found to be 
stronger at r = 0.59. The corrected strong positive correlation is to be expected. 
Since the optic nerve is comprised of retinal nerve axons, thinning of the RNFL 
should consequently result in a reduction in the optic nerve size and has been 
shown to do so in other studies. (5) Nevertheless, there was a fair amount of 
variability. The best linear best fit line only produced an r2 = 0.3482. Attempting to 
determine the degree of atrophy based purely on optic nerve size may not be a 
feasible endeavor. Additionally, the doubling of the correlation in response to 
removal of the three patients with hypersensitivity on their MRIs suggest that 
those measurements may indeed be inaccurate.  
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 At the orbital apex, the average diameter of the optic nerve is 1.5 mm. As 
the nerve travels towards the optic chiasm, the diameter of the nerve increases. 
However that average diameter value may not be the same in all individuals due 
to natural variation in the size of an optic nerve. One way to try and control for 
these differences is a comparison of optic nerves in patients with unilateral 
atrophy. Ideally, the healthy eye could serve as a control for that particular 
patient. It should be noted that while the non-afflicted eye could serve as a 
control, sometimes small variation exists even between a set of nerves in 
individuals as evidenced by the subjects in the MRI control group. This study 
utilized the records of ten patients with unilateral atrophy and no hyperintensity 
on MRI. The percentage difference between the nerve sizes was calculated. 
Comparing that data with the RNFL, there is a clear inverse relationship between 
the two parameters. The best fitted inverse equation produced an r2 = 0.63.  
  In mild atrophy cases, the percentage differences in the eyes ranged from 
10 to 20%. Such a small difference may not be significant enough for a diagnosis 
of atrophy based on MRI. However as the RNFL continues to thin, the 
percentage difference became more pronounced, particularly after the RNFL 
dropped below 70 μm. In this study, moderate and severe were defined as an 
RNFL thickness less than 70 μm and less than 50 μm respectively. It is apparent 
that the thinner the RNFL, the more likely MRI may be used for diagnostic 
purposes. So for severe and moderate unilateral cases, MRI might serve as a 
diagnostic tool; while for mild atrophy, it should not be used as such. From this 
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data set, it seems as though a maximum RNFL of 70 μm is the cutoff for effective 
diagnostic use of MRI. (Figure 13). Increasing the sample size could determine a 
more definitive cutoff or move the apparent cutoff point.  
 While gathering MRI data, the interpreting resident noted anecdotally that 
the optic nerve sheath seemed to decrease with decreasing optic nerve size. To 
qualitatively confirm this, the ratio of the optic nerve area to sheath area was 
calculated for pathological eyes. The average ratio was found to be 0.27 in 
atrophic eyes with a standard deviation of 0.08 and a variance of 0.01. A 
comparison of the ratio to RNFL revealed a weak positive correlation, r = 0.23, 
between the two parameters. A linear best fit model produced an r2 of 0.055. 
Therefore, this suggests that the sheath diameter may be decreasing as the 
atrophy worsens. In support of this observation, there are previous studies that 
have shown a correlation between thinning of the RNFL and decreasing optic 
nerve sheath area. (5) 
  The variation in the ratios could be a result of the underlying etiologies. 
Demyelinating diseases like optic neuritis associated with multiple sclerosis 
versus a toxic/nutritional neuropathy could affect myelin loss differently. 
Controlling for underlying pathologies may provide more information on this 
phenomenon and potentially demonstrate less deviation in the ratio per disease 
category. However in this investigation, there were an inadequate number of 
patients with any particular etiology to safely draw any inferences from. Future 
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studies could attempt to recruit more patients to be able to control by neuropathy 
and observe if and how this influences myelin loss.  
  To determine differences in the sets of eyes of patients with unilateral and 
bilateral optic atrophy, t-tests were performed on both the area difference 
between the two optic nerves and percentage differences in size between the 
two groups. The t-tests returned p-values of 0.092 and 0.328 respectively. 
Therefore at a significance level of 0.05, no discernable difference seems to exist 
between the two groups concerning absolute differences in area and percentage 
differences between the two nerves. The degree of atrophy most likely influences 
those values. By focusing on the sub-categories severe versus mild atrophy, 
there may exist a significant difference between patients with those afflictions. 
This study did not enroll enough unilateral patients for those subcategories to 
make that comparison.  
 Because of natural variance in nerve size, the MRI control group was 
included in the study. Enrolled subjects had no listed ocular conditions. Thus, 
their nerves were considered to be healthy. Their MRIs had been done through a 
seizure protocol which also allows visualization of the optic nerve. Analysis of 
their eyes revealed an average asymmetry of 0.3 mm2 between sets. This 
suggests a potential error source in percentage differences in unilateral patients, 
where the healthy nerve was considered as the normal for the other eye. 
However, since this variance between nerves affect all. The healthy nerve was a 
case control for patients with unilateral optic atrophy. 
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 As humans age, a reduction in the thickness of the RNFL is to be 
expected. (37) To control for natural loss in aging, a correlation of age to optic 
nerve size was calculated for the MRI control group and determined to be 
0.3063. Doing the same to the patient case group returned a correlation of r = 
0.1646. The z-test returned a p-value of 0.49 and thus the correlations are not 
significantly different from each other. To find no discernable difference between 
the two groups was unexpected. A potential explanation is that a reduction in 
RNFL thickness by age alone does not reach the detection threshold with MRI. It 
is also possible that the study was not been powered to detect this. This finding 
stresses the value of clinical examination for diagnosis and suggests that 
diagnosis may not be based on MRI alone. 
 This study included a small sample size of 27 patients with various degrees 
of atrophy for analysis. Initially, a total of 34 patients passed the initial screening. 
However in seven of those subjects, either the orbital MRI was unavailable in 
PACS, the MRI database, or the optic nerve was not clearly defined in the images. 
This lowered the sample size down to the 27 incorporated subjects.  
 When accessing these patients’ MRIs, it became apparent that the quality 
of the MRIs fluctuated to a certain extent. In some cases, the optic nerve was not 
sharply defined at the retrobulbar area. Due to this variance, MRI measurements 
were not all obtained at the same location as planned and instead were done at 
one of four locations. The reliability of any drawn conclusions could be reduced 
especially considering the optic nerve increases in size in its trajectory from when 
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it leaves the globe to when approaching the optic chiasm. Potential causes for the 
variation in quality are the underlying etiologies for optic nerve atrophy and patient 
induced errors. Some of the variation in MRIs were due to regions of 
hyperintensity. These regions may have blurred the optic nerve or sheath 
boundary, resulting in larger than actual measurements for those two areas.   
 Hyperintensity on the orbital MRIs could have been caused by a number of 
factors. The most probable source seems to be the underlying pathology. Certain 
diseases processes including demyelinating or inflammatory diseases and 
ischemia are known to result in white matter hyperintensity on MRIs. (35, 36) Of 
the three patients who were noted to have strong bright signals, two of the patients 
had inflammatory disorders (optic neuritis and neurosyphillis) and the third one had 
orbital apex syndrome which could have caused ischemia. In the patient diagnosed 
with optic neuritis and with spots of hypersensitivity on MRI, obtained MRI 
measurements were believed to be erroneous. The size of the optic nerve in the 
atrophic eye (RNFL = 24 μm) was measured to be 12.1 mm. This is nearly double 
the largest nerve size measurement which is from a healthy eye. This patient was 
determined to be a statistical anomaly and was removed from analysis. It should 
be noted that while two of the white matter hyperintense cases had an underlying 
inflammatory neuropathy, not all patients with that type of neuropathy had 
observed hyperintensity. Another cause for variation in image quality is patient 
induced errors. The orbital MRI procedure takes approximately 25 to 35 minutes 
to complete and requires patients to remain relatively still during the entire process. 
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Any movement by the patient during imaging may introduce motion artifacts onto 
the MRI scans.  
  In conclusion, MRI is undoubtedly a useful diagnostic tool for a multitude 
of diagnoses and disease monitoring purposes. However in cases of optic nerve 
atrophy, MRI seems to be limited to diagnostic assistance in moderate and 
severe cases of atrophy, situations where the RNFL drops to 70 μm or lower. It 
appears to be most useful in cases of unilateral atrophy. Even in unilateral 
patients, it does not appear to be a viable tool for cases of mild atrophy. 
However, the small sample size and variable image quality are the two main 
factors which limit accuracy of the data and any conclusions drawn from it, such 
as a cutoff of 70 μm. As it stands, MRI does seem to be a sensitive enough or 
predictive enough imaging modality to diagnose mild cases (RNFL > 75 μm). 
Since any atrophy of the retinal ganglion cells is irreversible, use of a more 
sensitive imaging modality may be imperative to reduce potential damage. OCT 
remains the standard for the diagnosis of optic nerve atrophy along with clinical 
examination.  
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